Volume | 6,025 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Camurus Ab | 0RD1 | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
101.20 | 101.20 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
29 | 6,025 | - | 101.20 - 101.20 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
05:45:03 | O | 222 | SEK 504.7257 | SEK |
Camurus Ab Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
5.62B | 55.54M | - | 1.72B | 431.44M | 7.77 | 13.03 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Camurus Ab News
Date | Time | Source | News Article |
---|---|---|---|
17/7/2023 | 15:40 | PR Newswire (US) | Camurus announces new Phase 3 data reinforcing long-term.. |
17/7/2023 | 15:36 | PR Newswire (US) | Camurus announces new Phase 3 data reinforcing long-term.. |
24/5/2023 | 13:25 | PR Newswire (US) | Camurus announces FDA approval of Brixadi™ for the treatment.. |
24/5/2023 | 13:17 | PR Newswire (US) | Camurus announces FDA approval of Brixadi™ for the treatment.. |
Historical 0RD1 Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 101.20 | 101.20 | 101.20 | 101.20 | 8,837 | 0.00 | 0.00% |
1 Month | 101.20 | 101.20 | 101.20 | 101.20 | 19,149 | 0.00 | 0.00% |
3 Months | 101.20 | 101.20 | 101.20 | 101.20 | 30,550 | 0.00 | 0.00% |
6 Months | 101.20 | 101.20 | 101.20 | 101.20 | 27,908 | 0.00 | 0.00% |
1 Year | 101.20 | 101.20 | 101.20 | 101.20 | 17,322 | 0.00 | 0.00% |
3 Years | 101.20 | 101.20 | 101.20 | 101.20 | 9,513 | 0.00 | 0.00% |
5 Years | 101.20 | 101.20 | 101.20 | 101.20 | 7,211 | 0.00 | 0.00% |